Rationale: Recurrent wheeze and asthma are thought to result from alterations in early life immune development following respiratory syncytial virus (RSV) infection. However, prior studies of the nasal immune response to infection have assessed only individual cytokines, which does not capture the whole spectrum of response to infection.
Acute respiratory infection (ARI) with respiratory syncytial virus (RSV) is one of the risk factors most strongly and consistently associated with asthma risk (1) (2) (3) . Human rhinovirus (HRV) has also been strongly associated with subsequent asthma risk (4, 5) . However, these viruses differ in their mode of entry into the cells and subsequent behavior (6) (7) (8) , therein we hypothesized, potentially evoking distinct immune-responses (9) . As the innate immune response is central to the initial defense against RSV (10) (11) (12) (13) , infection may contribute to early life reprogramming of an infant's immune response (14) (15) (16) (17) (18) . Prior studies have assessed only individual cytokines or immune cell lineage (19) (20) (21) (22) , which does not capture the whole spectrum of immune response to infection (23) . Advances in technologies and computational approaches make it possible to examine the immune-response pattern in response to an environmental risk factor, such as RSV, through analysis of multiple components of the immune system simultaneously (24, 25) . This integrative analytical approach identifies the central pathways and dynamic relationships among the myriad of immune-response mediators involved in the pathogenesis of early childhood wheezing.
Our objective was to understand how RSV may contribute to later childhood asthma by identifying infant immuneresponse patterns to RSV infection (which we term the viral-nasal immune-response pattern) at the site of infection, to compare it with another known common infant respiratory virus and asthma risk factor, HRV, and to establish pathways through which RSV immunomodulation may contribute to the development of childhood recurrent wheeze.
Methods

Population
The study was conducted on a subset of the ongoing INSPIRE (Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure) cohort (n = 193; 9.8%), for whom nasal immune-response mediators data were available during ARI with either RSV or HRV. The details of the cohort have been described previously (26) . Infancy is defined as firstyear of child life. Recurrent wheeze at age 1 and 2 years was assessed as a known precursor to later childhood asthma, and time points are the most current available for this ongoing longitudinal birth cohort study. The institutional review board of Vanderbilt University approved this study.
Acute Respiratory Illness Visit and Nasal Wash Sample Collection
Infants underwent biweekly surveillance for ARI during winter viral season (November through March). If infants met predefined criteria for ARI, a respiratory illness visit was conducted to assess disease severity and a nasal wash sample was collected (26) . The nasal wash was performed using 5 ml of sterile saline and immediately placed at 4 8 C for transport and then snap frozen at 280 8 Two replicates of each sample assay were performed on plates with 96 wells each. The multiplex bead assays included 53 immune-response analytes: VEGF (vascular endothelial growth factor), G-CSF (granulocyte colony-stimulating factor), GM-CSF (granulocyte-macrophage colony-stimulating factor), EGF (epidermal growth factor), FGF (fibroblast growth factor), eotaxin-1/ CCL11, eotaxin-2/CCL24, eotaxin-3/CCL26, MCP-1 (monocyte chemotactic protein-1)/ CCL2, MCP-2/CCL8, MCP-4/CCL13, I-309/ CCL1, IL-16, TARC (thymus-and activationregulated chemokine)/CCL17, 6CKine (chemokine with 6 cysteines)/CCL21, LIF (leukemia inhibitory factor), TPO (thrombopoietin), SCF (stem cell factor), TSLP (thymic stromal lymphopoietin), TRAIL (TNF [tumor necrosis factor]-related apoptosis-inducing ligand), BCA-1 (B cell-attracting chemokine-1), CTACK (cutaneous T cell-attracting chemokine)/CCL27, SDF-1ab (stromal cell-derived factor-1ab)/ CXCL12, ENA-78 (epithelial cell-derived neutrophil attractant with 78 amino acids)/CXCL5, IL-1b, IL-1RA (receptor antagonist), IL-2, IL-2R, IL-7, IL-10,  IL-13, IL-4, IL-5, IL-6, IL-8, IL-12, IL-15, IL-17,  IL-20, IL-21, IL-23, IL-28A, IL-33, IFN-g, IFN-a, TNF-a, RANTES (regulated on activation, normal T cell expressed and secreted)/CCL5, MIP-1a (macrophage inflammatory protein1a)/CCL3, MIP-1b/CCL4, MIP-1d/CCL15, IP-10/ CXCL10, MIG (monokine induced by IFN-g)/CXCL9, and HGF (human growth factor). A blank well was used to estimate the background. HGF was below detectable levels in more than 50% of the infant nasal wash sample, and was therefore removed from further analysis.
Infant Viral-Nasal Immune-Response Pattern Analytes Data Processing Because our primary interest was to determine the pattern of immuneresponses, we used the relative abundances of the analytes, which is fluorescence intensity (FI), in our analysis (27, 28) . This is an approach first promoted by Won and colleagues to process the individual bead FI data and has been validated (28, 29) and used in a number of studies as alternative approach to overcome several issues with curve-based FI data (30) (31) (32) (33) . Won and coworkers' (27) (34, 35) .
The assays were originally processed using the standard curve methods; therefore, we used known standard replicates between plates. In addition, we used standard curve method derived concentration to test for statistically significant differences between plates and did not find any.
Statistical Analysis
We normalized the FI data using the median of all FI values to guard against any systematic variance introduced by technical factors, such as sample-to-sample cell count differences, suboptimal antibodies and fluorescence marker combinations, instrument variability over time, changes in reagent lots, and variability in sample handling (36, 37) . Finally, we scaled the normalized and log transformed values using the Pareto scaling method (38) . The multivariate kernel density graph of the raw data and the processed data is provided in the online supplement (see Figure E1 in the online supplement).
We first assessed the number of infant nasal immune-response pattern using principal component (PC) analysis and hierarchical clustering. We then assessed the statistically significant distance between immune-response patterns with Gaussian mixture model. Subsequently, we used the number of patterns observed in the PC analysis, hierarchical clustering, and Gaussian mixture model to cluster the infants with k-means clustering method. The immune-response patterns were visualized using heatmaps, where k-mean cluster labels were included. We then used partial least square discriminant analysis (PLS-DA) and orthogonal PLS-DA to obtain a ranked list of cytokines ordered by their variable importance in projection score based on their ability to differentiate between the identified clusters. This ranking was validated with five-fold crossvalidation. Finally, we used multivariable logistic regression to assess the association of the clusters identified with recurrent wheezing during the first and second year of life, the most recent time point available for the birth cohort. The model was adjusted for infant age at ARI, sex, ARI severity score, maternal asthma, maternal To explore the variation in the infant viral-nasal immune-response mediator data we performed PC analysis of the immune-response mediators and evaluated the association of PCs with non-immuneresponse covariates (see the RESULTS section of the online supplement and Figure E2 ). The first, second, and third PCs accounted for 45.1%, 10.7%, and 6.7% of the variation in the viral-nasal immune-response mediators data. The first and second PCs, which cumulatively account for 55.8% of the variation in the data (see Figure E2 ), were associated with age at ARI, where older age (in months) is negatively associated with PC1 (ordinary least square regression, b = 21.19; P , 0.001) and positively associated with PC2 (ordinary least square regression, b = 0.59; P = 0.002). Figure E3B ). The variation in the immune-response mediators data caused by virus type was small, but biologically meaningful, characterizing the comparison of immune response to RSV and to that of HRV.
Infant Viral-Nasal Immune-Response Pattern
To identify immune-response mediator patterns to RSV and HRV acute respiratory illness, we next used a combination of clustering approaches on each separately. Hierarchical clustering and Gaussian mixture model or latent class clustering, a modelbased soft clustering approach, followed by k-mean clustering identified two distinct immune-response clusters each for RSV and HRV ARI. We refer to the clusters as cluster-1RSV (n = 47) and cluster-2RSV (n = 61), and cluster-1HRV (n = 45) and cluster-2HRV (n = 57) hereafter. The intensity of type-2 and type-17 immune response to the viruses differed between the two identified clusters as visualized using k-mean clusters labeled heatmap (Figure 1 ). To understand the impact of the observed distinct infant immune-response cluster during RSV or HRV ARI on the development of recurrent wheezing, we performed adjusted and unadjusted logistic regression assessing the association between first and second year recurrent wheezing and the identified immune-response clusters (Table 2 ; see Tables E1 and Table E2 ). The RSV cluster characterized by type-2 and type-17 cytokine dominance (cluster-2RSV) was significantly associated with wheezing at 1 year (adjusted OR, 4.78; 95% CI, 1.73-13.24) and at 2 years (adjusted OR, 2.83; 95% CI, 1.08-7.44). The associations between HRV cluster (cluster-2HRV) and recurrent wheezing were not statistically significant at any time point (see the RESULTS section of the online supplement and Table E2 ). The frequency of recurrent wheeze by virus, immune-response cluster, and year is provided in Table E3 .
What Are the Most Important Immune-Response Mediators in Distinguishing the Infant Viral-Nasal Immune-Response Clusters?
We used PLS-DA to establish whether the clusters were distinctly separated ( Figure 2 ) and to identify important mediators that distinguish the two immune-response clusters for each viral agent ( Figure 3 ). The PLS-DA variable importance in projection procedure ranked the mediators according to their importance in distinguishing the two clusters for each virus (Figure 3 ; see the RESULTS section of the online supplement).
Infant Viral-Nasal Immune-Response Mediators Network and Topologic Analysis
To further characterize the differential infant immune response to RSV and HRV,
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we used partial correlations with an alpha threshold of P less than 0.05 for constructing the network of immune responses during RSV and HRV ARIs (Figure 4 ; see the RESULTS section of the online supplement). Topologic analysis focusing on the centrality of the network revealed mediators that play central roles in the immune response to these viruses (Figure 4) . IL-17 and IL-1RA were central to the immune response to RSV. MCP-2/CCL8, TSLP, eotaxin-2/CCL24, IL-15, ENA-78/CXCL5, and 6Ckine/CCL21 were also important hubs in response to RSV. The network analysis of HRV immune response showed that TARC/CCL17 and SCF were at the center of the immune response with the highest between-centrality score. EGF, VEGF, IL-13, IL-28a, eotaxin-2/CCL24, IL-1RA, and GM-CSF had high betweennesscentrality scores during HRV-associated ARI. As noted, TARC/CCL17 and SCF were elevated in the cluster with type-2 and type-17 characteristics (cluster-2HRV).
Discussion
Using a prospective birth cohort designed to identify the first RSV infection during infancy and track ARIs throughout RSV season, we identified two unique viral-nasal immune-response clusters during acute RSV infection, one of which identifies infants at increased risk of childhood recurrent wheeze. To determine if these findings were specific to RSV, we compared the viral-nasal immune-response patterns of infants with RSV ARI to those with HRV ARI, demonstrating some overlap in profiles, but differences between the immune-mediator responses to the two viruses.
One of immune-response clusters we identified both for RSV and HRV (cluster-2RSV and cluster-2HRV), and which was associated with recurrent wheeze in RSV ARI, was characterized by a profile of increased type-2 and type-17 immuneresponse mediators. The mediators that have been previously demonstrated to be instrumental in clearing RSV (42) (43) (44) (45) (46) and HRV (47) (48) (49) (50) (51) (52) (53) (54) (55) . In cluster-2RSV and cluster-2HRV, the level of IFN-g was elevated and the level of IL-10 was decreased, which is consistent with published experimental evidence showing that IL-10 deficiency enhances the inflammatory effects of type-2 cytokines and chemokines (56) (57) (58) ).
An infant immune-response cluster to RSV ARI (cluster-2RSV) that was significantly associated with recurrent wheeze was characterized by increased type-2 and type-17 immune mediators, and decreased immunoregulatory and non-IFN antiviral immune-response mediators (TNF-a and macrophages). In comparison, we did not observe this association in HRV-infected infants. Prior studies that have compared individual cytokine concentrations between wheezers and nonwheezers have demonstrated increased concentrations of IFN-g, IL-2, MIP-1a, and MIP-1b in nasopharyngeal aspirates among recurrent wheezers (22), consistent with the expanded immune-response profile of the RSV cluster that was associated with recurrent wheezing in our study. Because there is a difference in severity of ARI caused by the two viruses, we not only adjusted for severity of ARI but we did a matched analysis, which did not yield different results.
Based on network analyses, we demonstrated differences in the immune mediators central to the immune responses to each of these viruses. Topologic analysis of the immune mediators in the network, and the relationship between individual mediators may shed light on potential synergy, or lack thereof, in immune response to each virus. Between centrality analyses of the networks revealed that type-2 and type-17 cytokines were central to the immune response to RSV, whereas growth factors and chemokines were central to the immune response to HRV.
The observed negative correlation between IL-17 and IL-1RA (receptor antagonist) is explained by animal experiments that demonstrated IL-1RA suppresses IL-1R expression and IL-1RA-deficient mice exhibit elevated IL-1R expression, which plays a critical role in inducing IL-17 production (59). It has been also shown that IL-17 can enhance the RSV-induced production of neutrophilattractant chemokines (60, 61) , thereby increasing neutrophil recruitment and contributing to heightened lung inflammation (62) . It is important to note Definition of abbreviations: CI = confidence interval; HRV = human rhinovirus; OR = odds ratio; RSV = respiratory syncytial virus. *Recurrent wheezing was defined as wheezing frequency .3 episodes or asthma medication use in the past 12 months for every year. † Adjusted for: sex, age at acute respiratory infection, severity of acute respiratory infection, time from symptom onset to nasal wash sample (d), maternal asthma, maternal education level (see Tables E2 and E3 for details on covariates). that high IL-17 and low IL-1RA were the hallmark of the RSV cluster that was associated with recurrent wheeze (cluster-2RSV). The negative correlation between EGF and type-2 immune-response mediators (IL-13 and IL-2) during HRVassociated ARI is interesting because EGF has a role in cell proliferation and tissue repair; it may protect the epithelial cell from inflammatory immune-response mediators or virus-mediated damage (63) . However, EGF has a role in viral entry, delayed apoptosis during ARIs associated with both HRV and RSV, and promotes viral replication by suppressing antiviralrelated immune mediators (63) (64) (65) (66) (67) . In addition, our findings demonstrate a prominent role of EGF in the immune response to HRV. Supportive of the influence of EGF in HRV infection, several prior studies have shown that HRVassociated asthma exacerbations are characterized by major airway mucin production involving a novel EGFRdependent pathway (68, 69) . These findings are consistent with the literature that RSV, via the various immunomodulatory mechanisms, is acting at every level of defense (18, 70) , including on the early life immune system that is inexperienced and vulnerable to modulation (71) (72) (73) . This enhanced understanding of the changes in the immune system during first year RSV infections may help to explain the pathogenesis of RSV and its strong association with childhood wheeze and asthma. This study is innovative in the use of a birth cohort specifically designed to capture the first infant RSV infection with ARI surveillance throughout winter virus season and use of high throughput infant nasal immune-response mediator data in combination with computational methods to discover and characterize two novel clusters and identify those mediators that are central in the immune response to RSV and HRV. Despite its novelty in linking changes in nasal immune response to specific viral infection and subsequent recurrent wheeze, this study has some limitations that should be considered. First, even though we ascertained the number of reported days from ARI symptom onset to sample collection, in human studies of natural infection, it is not possible to know the exact number of days from actual viral infection to the nasal sampling assessment of the immune response to ARI. To address this issue, we adjusted for the number of days from symptom onset to the nasal sample collection to account for differences in viral kinetics.
Second, our study of ARIs includes infections of varied severity level, including both lower and upper respiratory tract infections. Nevertheless, we note that our findings did not change when we adjusted the model for disease severity using a continuous respiratory severity score and a dichotomous measure of infection severity, lower respiratory tract infection versus upper respiratory tract infection. We additionally conducted the analyses excluding those who were hospitalized, and the results did not change. Racial/ethnic differences as a proxy for genetic and cultural differences, which may influence diet and other lifestyle factors, may influence immune response. However, race/ethnicity equally distributed between the immuneresponse clusters and adjusting for it did not change our result. Finally, we used the same sample for testing and validating the results in the discriminant analysis steps. This was done because the sample size was not large enough to split into training and validation sets; however, we used bootstrap resampling for validation of the separation between the clusters, which is standard for machine learning approaches. We also confirmed the existence and significant difference between the two clusters using Gaussian mixture model.
Conclusions
Our findings identify two distinct infant nasal immune-response clusters in response to infant RSV infection, one of which is associated with increased risk of subsequent wheeze. These findings support the concept that the immune-response pattern to RSV is an early insight into host response to environmental stimuli that is a known risk factor for subsequent wheeze, and that infant RSV infection may inhibit immunoregulatory and non-IFN antiviral response mediators and promote a type-2 and type-17 immune phenotype. The findings provide new insights into the distinct infant nasal immune response to ARI and its associations with subsequent childhood wheeze, which may enhance the understanding of the pathways through which RSV may be associated with the development of asthma. n Author disclosures are available with the text of this article at www.atsjournals.org. 
